Fri 2/28/2020 05:28 ET
DJIA25766.641138.894.42%TELCO178.906.463.61%GOLD1627.1515.300.94%Shanghai2890.5697.413.37%
S&P 5002978.76131.664.42%BANKS433.8319.614.52%OIL45.511.583.47%BITCOIN8648.98143.571.66%
NASDAQ8566.48394.914.61%PHARM575.4516.402.85%US/EU1.100.000.00%Futures2920.3836.501.25%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Neurocrine Biosciences - NBIX   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add NBIX
  
From: blacksheep (Rep: 332)Date: 04/12/2017 08:32
Forum: Neurocrine Biosciences - Msg #1114Thread #673920731 (Rec: 0)
$100/sh stock? BMO saying the positive Ingrezza label along with other catalysts opens pathway


Neurocrine Biosciences (NASDAQ:NBIX) +14.3% AH after saying it received FDA approval of its Ingrezza capsules as the first and only approved treatment for adults with tardive dyskinesia neurological disorder.

NBIX says the drug will be in the distribution channel next week and will be available through a select pharmacy network.

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser blacksheep: Reward | Watch | IgnoreNBIX: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add NBIX
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.